Log in

NYSE:CGCCanopy Growth Stock Price, Forecast & News

$17.30
-0.12 (-0.69 %)
(As of 07/13/2020 04:00 PM ET)
Add
Compare
Today's Range
$17.03
Now: $17.30
$18.42
50-Day Range
$15.91
MA: $17.12
$21.72
52-Week Range
$9.00
Now: $17.30
$36.74
Volume6.54 million shs
Average Volume7.10 million shs
Market Capitalization$6.07 billion
P/E RatioN/A
Dividend YieldN/A
Beta2.58
Canopy Growth Corporation, together with its subsidiaries, engages in growing, possession, and sale of medical cannabis in Canada. Its products include dried flowers, oils and concentrates, softgel capsules, and hemps. The company offers its products under the Tweed, Black Label, Spectrum Cannabis, DNA Genetics, Leafs By Snoop, CraftGrow, and Foria brand names. It also offers its products through Tweed Main Street, a single online platform that enables registered patients to purchase medicinal cannabis from various producers across various brands. Canopy Growth Corporation has a clinical research partnership with NEEKA Health Canada to investigate the efficacy of cannabinoids for the treatment of post-concussion neurological diseases in former NHL players; and partnership with Parent Action on Drugs. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation is headquartered in Smiths Falls, Canada.
Read More
Canopy Growth logo

Beat the Market (BTM) Rank

Analyst Opinion: 4.0Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.45 out of 5 stars


Industry, Sector and Symbol

Industry Medicinals & botanicals
Sub-IndustryCannabis
SectorMedical
CUSIPN/A
CIKN/A
Phone855-558-9333

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$297.34 million
Cash Flow$1.57 per share
Book Value$10.95 per share

Profitability

Net Income$-993,370,000.00
Net Margins-752.54%

Miscellaneous

Employees4,434
Market Cap$6.07 billion
Next Earnings Date8/12/2020 (Estimated)
OptionableOptionable

Receive CGC News and Ratings via Email

Sign-up to receive the latest news and ratings for CGC and its competitors with MarketBeat's FREE daily newsletter.

Canopy Growth (NYSE:CGC) Frequently Asked Questions

How has Canopy Growth's stock been impacted by COVID-19 (Coronavirus)?

Canopy Growth's stock was trading at $13.35 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, CGC shares have increased by 29.6% and is now trading at $17.30. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Canopy Growth?

22 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Canopy Growth in the last year. There are currently 3 sell ratings, 14 hold ratings and 5 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Canopy Growth.

When is Canopy Growth's next earnings date?

Canopy Growth is scheduled to release its next quarterly earnings announcement on Wednesday, August 12th 2020. View our earnings forecast for Canopy Growth.

How were Canopy Growth's earnings last quarter?

Canopy Growth Corp (NYSE:CGC) issued its earnings results on Friday, May, 29th. The marijuana producer reported ($1.16) earnings per share for the quarter, missing the Zacks' consensus estimate of ($0.30) by $0.86. The marijuana producer earned $80.46 million during the quarter, compared to analyst estimates of $94.65 million. Canopy Growth had a negative net margin of 752.54% and a negative return on equity of 20.66%. View Canopy Growth's earnings history.

What price target have analysts set for CGC?

22 Wall Street analysts have issued 1-year price targets for Canopy Growth's shares. Their forecasts range from $15.60 to $60.00. On average, they anticipate Canopy Growth's share price to reach $31.92 in the next year. This suggests a possible upside of 84.5% from the stock's current price. View analysts' price targets for Canopy Growth.

Has Canopy Growth been receiving favorable news coverage?

News stories about CGC stock have been trending neutral on Tuesday, according to InfoTrie. The research group rates the sentiment of press coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Canopy Growth earned a news impact score of 0.2 on InfoTrie's scale. They also gave news stories about the marijuana producer a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an impact on the company's share price in the next few days. View the latest news about Canopy Growth.

Are investors shorting Canopy Growth?

Canopy Growth saw a increase in short interest in June. As of June 15th, there was short interest totaling 45,800,000 shares, an increase of 6.2% from the May 31st total of 43,130,000 shares. Based on an average trading volume of 7,210,000 shares, the short-interest ratio is currently 6.4 days. Currently, 21.2% of the shares of the company are sold short. View Canopy Growth's Current Options Chain.

Who are some of Canopy Growth's key competitors?

What other stocks do shareholders of Canopy Growth own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Canopy Growth investors own include NVIDIA (NVDA), Alibaba Group (BABA), Micron Technology (MU), General Electric (GE), Aurora Cannabis (ACB), Cronos Group (CRON), Canopy Growth (WEED), Tilray (TLRY), KushCo (KSHB) and Aurora Cannabis (ACB).

Who are Canopy Growth's key executives?

Canopy Growth's management team includes the following people:
  • Mr. Bruce A. Linton, Co-Founder, Chairman & Co-CEO (Age 52)
  • Mr. Mark Anthony Nicholas Zekulin, Pres & Co-CEO
  • Mr. Timothy Rob Saunders, Exec. Officer
  • Mr. Rade Kovacevic, Exec. VP
  • Mr. Mike Lee, Acting Chief Financial Officer

What is Canopy Growth's stock symbol?

Canopy Growth trades on the New York Stock Exchange (NYSE) under the ticker symbol "CGC."

Who are Canopy Growth's major shareholders?

Canopy Growth's stock is owned by many different institutional and retail investors. Top institutional investors include Investors Financial Group LLC (0.00%), Aua Capital Management LLC (0.00%), Exane Derivatives (0.00%), Tsfg LLC (0.00%) and Modus Advisors LLC (0.00%).

Which major investors are selling Canopy Growth stock?

CGC stock was sold by a variety of institutional investors in the last quarter, including Tsfg LLC.

Which major investors are buying Canopy Growth stock?

CGC stock was bought by a variety of institutional investors in the last quarter, including Investors Financial Group LLC, Aua Capital Management LLC, Exane Derivatives, and Modus Advisors LLC.

How do I buy shares of Canopy Growth?

Shares of CGC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Canopy Growth's stock price today?

One share of CGC stock can currently be purchased for approximately $17.30.

How big of a company is Canopy Growth?

Canopy Growth has a market capitalization of $6.07 billion and generates $297.34 million in revenue each year. The marijuana producer earns $-993,370,000.00 in net income (profit) each year or $1.32 on an earnings per share basis. Canopy Growth employs 4,434 workers across the globe.

What is Canopy Growth's official website?

The official website for Canopy Growth is www.canopygrowth.com.

How can I contact Canopy Growth?

Canopy Growth's mailing address is 1 HERSHEY DRIVE, SMITH FALLS A6, K7A0A8. The marijuana producer can be reached via phone at 855-558-9333 or via email at [email protected]

This page was last updated on 7/14/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.